×
For best experience we recommend to activate Javascript in your browser.
Recombinant CD276 (Enoblituzumab Biosimilar) antibody
The Mammalian Cells Monoclonal anti-CD276 (Enoblituzumab Biosimilar) antibody has been validated for not_set. It is suitable to detect CD276 (Enoblituzumab Biosimilar) in samples from Human.
Catalog No. ABIN7488091
$336.06
Plus shipping costs $50.00
1 mg ABIN7470126
100 μg ABIN7488091
1 mg ABIN7470126
100 μg ABIN7488091
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant CD276 (Enoblituzumab Biosimilar) antibody (ABIN7488091)
Target
CD276 (Enoblituzumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Grade
Research Grade
Product Details anti-CD276 (Enoblituzumab Biosimilar) Antibody
(hide)
Expression System
Mammalian cells
Purpose
Enoblituzumab Biosimilar - Anti-CD276, B7-H3 mAb
Characteristics
Antibody Type: IgG1-kappa
Purification
Recombinant antibody expressed in mammalien cells and purified.
Isotype
IgG1 kappa
Application Details
(hide)
Restrictions
For Research Use only
Handling
(hide)
Buffer
PBS buffer pH 7.5
Storage
-80 °C
Storage Comment
store at -80°C
Target Details for CD276 (Enoblituzumab Biosimilar)
(hide)
Target
CD276 (Enoblituzumab Biosimilar)
Target Type
Biosimilar
Background
MG-A271
Recently viewed
(hide)
Chat with us , powered by LiveChat